跳至主要内容
临床试验/ACTRN12613000348752
ACTRN12613000348752已完成4 期

Amongst women undergoing caesarean section for placenta praevia does prophylacitc use of a Bakri intrauterine balloon immediately following delivery of placenta compared with usual measures reduce blood loss and/or the need for additional surgical/pharmacological measures to reduce blood loss

Michael Beckmann0 个研究点目标入组 100 人开始时间: 2013年4月2日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • All women with live singleton pregnancies =24+0 weeks undergoing caesarean section in the setting of a known placenta praevia (leading edge of placenta <20mm from the cervical os) will be suitable for inclusion in this study

排除标准

  • Multiple pregnancy
  • Intrauterine Fetal Death
  • Suspected placenta accreta
  • Congenital abnormalities of the uterine cavity
  • Submucosal uterine fibroids >5cm
  • Women who give birth vaginally
  • Women aged <18 years
  • Inability to consent

研究者

发起方
Michael Beckmann

相似试验